Anna-sophia Kiang
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Enhanced retinal pigment epithelial cells as a delivery vehicle for retinal disease.
Journal: Molecular therapy. Methods & clinical development
Published: August 19, 2024
Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa.
Journal: Genes
Published: November 02, 2020
siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model.
Journal: Molecular therapy. Methods & clinical development
Published: May 11, 2020
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy.
Journal: BMJ open ophthalmology
Published: March 09, 2020
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma.
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma.
Journal: Human molecular genetics
Published: December 09, 2016
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration.
Journal: Science translational medicine
Published: April 04, 2014
Antioxidant therapy for retinal disease.
Journal: Advances in experimental medicine and biology
Published: March 26, 2014
Inflammation in age-related macular degeneration.
Journal: Advances in experimental medicine and biology
Published: March 26, 2014
An overview of the involvement of interleukin-18 in degenerative retinopathies.
Journal: Advances in experimental medicine and biology
Published: March 26, 2014
Current therapeutic strategies for P23H RHO-linked RP.
Journal: Advances in experimental medicine and biology
Published: March 26, 2014
Last Updated: 09/26/2026